Multi-parameter fluorescence-activated cell sorting and analysis of stem and progenitor cells in myeloid malignancies

Best Practice & Research Clinical Haematology - Tập 23 - Trang 391-401 - 2010
Britta Will1, Ulrich Steidl1
1Albert Einstein College of Medicine, Department of Cell Biology & Albert Einstein Cancer Center, Chanin Institute for Cancer Research, Rm. #606, 1300 Morris Park Avenue, NY 10461, USA

Tài liệu tham khảo

Berenson, 1988, Antigen CD34+ marrow cells engraft lethally irradiated baboons, J Clin Invest, 81, 951, 10.1172/JCI113409 Srour, 1991, Human CD34+ HLA-DR− bone marrow cells contain progenitor cells capable of self-renewal, multilineage differentiation, and long-term in vitro hematopoiesis, Blood Cells, 17, 287 Terstappen, 1991, Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38− progenitor cells, Blood, 77, 1218, 10.1182/blood.V77.6.1218.1218 Craig, 1993, Expression of Thy-1 on human hematopoietic progenitor cells, J Exp Med, 177, 1331, 10.1084/jem.177.5.1331 Huang, 1994, Lymphoid and myeloid differentiation of single human CD34+, HLA-DR+, CD38− hematopoietic stem cells, Blood, 83, 1515, 10.1182/blood.V83.6.1515.1515 Berardi, 1995, Functional isolation and characterization of human hematopoietic stem cells, Science, 267, 104, 10.1126/science.7528940 Miller, 1999, Single adult human CD34(+)/Lin−/CD38(−) progenitors give rise to natural killer cells, B-lineage cells, dendritic cells, and myeloid cells, Blood, 93, 96, 10.1182/blood.V93.1.96 Manz, 2002, Prospective isolation of human clonogenic common myeloid progenitors, Proc Natl Acad Sci U S A, 99, 11872, 10.1073/pnas.172384399 Galy, 1995, Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset, Immunity, 3, 459, 10.1016/1074-7613(95)90175-2 Goodell, 1996, Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo, J Exp Med, 183, 1797, 10.1084/jem.183.4.1797 Zhou, 2001, The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype, Nat Med, 7, 1028, 10.1038/nm0901-1028 Kim, 2002, The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells, Clin Cancer Res., 8, 22 Challen, 2009, Mouse hematopoietic stem cell identification and analysis, Cytometry A, 75, 14, 10.1002/cyto.a.20674 Eaker, 2004, Detection and enrichment of hematopoietic stem cells by side population phenotype, Methods Mol. Biol., 263, 161 Pearce, 2007, The combined use of Hoechst efflux ability and aldehyde dehydrogenase activity to identify murine and human hematopoietic stem cells, Exp Hematol, 35, 1437, 10.1016/j.exphem.2007.06.002 Moshaver, 2008, Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia, Stem Cells, 26, 3059, 10.1634/stemcells.2007-0861 Matsui, 2008, Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance, Cancer Res., 68, 190, 10.1158/0008-5472.CAN-07-3096 Kastan, 1990, Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells, Blood, 75, 1947, 10.1182/blood.V75.10.1947.1947 Jones, 2009, Circulating clonotypic B cells in classic Hodgkin lymphoma, Blood, 113, 5920, 10.1182/blood-2008-11-189688 Jones, 1995, Assessment of aldehyde dehydrogenase in viable cells, Blood, 85, 2742, 10.1182/blood.V85.10.2742.bloodjournal85102742 Pearce, 2005, Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples, Stem Cells, 23, 752, 10.1634/stemcells.2004-0292 Hess, 2004, Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity, Blood, 104, 1648, 10.1182/blood-2004-02-0448 Haase, 1995, Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations, Blood, 86, 2906, 10.1182/blood.V86.8.2906.2906 Mehrotra, 1995, Cytogenetically aberrant cells in the stem cell compartment (CD34+lin−) in acute myeloid leukemia, Blood, 86, 1139 Nilsson, 2000, Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level, Blood, 96, 2012, 10.1182/blood.V96.6.2012 van Rhenen, 2005, High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival, Clin. Cancer Res., 11, 6520, 10.1158/1078-0432.CCR-05-0468 Nilsson, 2007, The molecular signature of MDS stem cells supports a stem-cell origin of 5q myelodysplastic syndromes, Blood, 110, 3005, 10.1182/blood-2007-03-079368 Nilsson, 2002, Involvement and functional impairment of the CD34(+)CD38(−)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8, Blood, 100, 259, 10.1182/blood-2001-12-0188 Delhommeau, 2009, Mutation in TET2 in myeloid cancers, N Engl J Med, 360, 2289, 10.1056/NEJMoa0810069 Jamieson, 2004, Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML, N Engl J Med, 351, 657, 10.1056/NEJMoa040258 Steidl, 2006, Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells, Nat Genet, 38, 1269, 10.1038/ng1898 Steidl, 2007, A distal single nucleotide polymorphism alters long-range regulation of the PU.1 gene in acute myeloid leukemia, J Clin Invest, 117, 2611, 10.1172/JCI30525 Majeti, 2009, Dysregulated gene expression networks in human acute myelogenous leukemia stem cells, Proc Natl Acad Sci U S A, 106, 3396, 10.1073/pnas.0900089106 Saito, 2010, Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells, Sci Transl Med, 2, 17ra9, 10.1126/scitranslmed.3000349 Lapidot, 1994, A cell initiating human acute myeloid leukaemia after transplantation into SCID mice, Nature, 367, 645, 10.1038/367645a0 Bonnet, 1997, Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell, Nat Med, 3, 730, 10.1038/nm0797-730 Blair, 1997, Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo, Blood, 89, 3104, 10.1182/blood.V89.9.3104 Blair, 1998, Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34(+)/CD71(−)/HLA-DR−, Blood, 92, 4325, 10.1182/blood.V92.11.4325 Wojiski, 2009, PML-RARα initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitors, Leukemia, 23, 1462, 10.1038/leu.2009.63 Taussig, 2010, Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34− fraction, Blood, 115, 1976, 10.1182/blood-2009-02-206565 Jordan, 2000, The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells, Leukemia, 14, 1777, 10.1038/sj.leu.2401903 Jin, 2009, Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells, Cell. Stem Cell., 5, 31, 10.1016/j.stem.2009.04.018 Guzman, 2001, Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells, Blood, 98, 2301, 10.1182/blood.V98.8.2301 Jin, 2006, Targeting of CD44 eradicates human acute myeloid leukemic stem cells, Nat Med, 12, 1167, 10.1038/nm1483 Hosen, 2007, CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia, Proc Natl Acad Sci U SA, 104, 11008, 10.1073/pnas.0704271104 van Rhenen, 2007, The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells, Blood, 110, 2659, 10.1182/blood-2007-03-083048 Jaiswal, 2009, CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis, Cell, 138, 271, 10.1016/j.cell.2009.05.046 Guzman, 2005, The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells, Blood, 105, 4163, 10.1182/blood-2004-10-4135 Guzman, 2007, An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells, Blood, 110, 4427, 10.1182/blood-2007-05-090621 Wang, 2005, Cancer stem cells: lessons from leukemia, Trends Cell Biol, 15, 494, 10.1016/j.tcb.2005.07.004 Majeti, 2009, CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells, Cell, 138, 286, 10.1016/j.cell.2009.05.045 Manz, 2009, Renaissance for mouse models of human hematopoiesis and immunobiology, Nat Immunol, 10, 1039, 10.1038/ni1009-1039 Spangrude, 1993, Mouse strain variability in the expression of the hematopoietic stem cell antigen Ly-6A/E by bone marrow cells, Blood, 82, 3327, 10.1182/blood.V82.11.3327.3327 Spangrude, 1988, Purification and characterization of mouse hematopoietic stem cells, Science, 241, 58, 10.1126/science.2898810 Akashi, 2000, A clonogenic common myeloid progenitor that gives rise to all myeloid lineages, Nature, 404, 193, 10.1038/35004599 Kondo, 1997, Identification of clonogenic common lymphoid progenitors in mouse bone marrow, Cell, 91, 661, 10.1016/S0092-8674(00)80453-5 Wilson, 2007, Dormant and self-renewing hematopoietic stem cells and their niches, Ann N Y Acad Sci, 1106, 64, 10.1196/annals.1392.021 Osawa, 1996, Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell, Science, 273, 242, 10.1126/science.273.5272.242 Rasko, 1995, The flt3/flk-2 ligand: receptor distribution and action on murine haemopoietic cell survival and proliferation, Leukemia, 9, 2058 Christensen, 2001, Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells, Proc Natl Acad Sci U S A, 98, 14541, 10.1073/pnas.261562798 Adolfsson, 2001, Upregulation of Flt3 expression within the bone marrow Lin(−)Sca1(+)c-kit(+) stem cell compartment is accompanied by loss of self-renewal capacity, Immunity, 15, 659, 10.1016/S1074-7613(01)00220-5 Kiel, 2005, SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells, Cell, 121, 1109, 10.1016/j.cell.2005.05.026 Yokota, 2009, The endothelial antigen ESAM marks primitive hematopoietic progenitors throughout life in mice, Blood, 113, 2914, 10.1182/blood-2008-07-167106 Yilmaz, 2006, SLAM family markers are conserved among hematopoietic stem cells from old and reconstituted mice and markedly increase their purity, Blood, 107, 924, 10.1182/blood-2005-05-2140 Weksberg, 2008, CD150− side population cells represent a functionally distinct population of long-term hematopoietic stem cells, Blood, 111, 2444, 10.1182/blood-2007-09-115006